Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.39 |
| ▸ | NOS2 | P35228 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9004358 | 0.87 | CYP1A2 (0.56) | CYP1A2LMNAMAPK1HTTNOS1 | |
| SCHEMBL3962258 | 0.86 | CYP1A2 (0.58) | CYP1A2LMNAMAPK1HTTNOS1 | |
| SCHEMBL74183 | 0.83 | — | — | |
| SCHEMBL1193058 | 0.83 | — | — | |
| SCHEMBL4860255 | 0.82 | CYP1A2 (0.43) | CYP1A2NOS1NOS2 | |
| SCHEMBL7471375 | 0.81 | CYP1A2 (0.48) | CYP1A2LMNAMAPK1HTTNOS1 | |
| SCHEMBL25389971 | 0.80 | CYP1A2 (1.00) | CYP1A2LMNAMAPK1HTTNOS1 | |
| Butylcyclohexane SCHEMBL2429501 | 0.80 | CYP1A2 (1.00) | CYP1A2LMNAMAPK1HTTNOS1 | |
| Ammonia Solution, Strong SCHEMBL6351644 | 0.80 | — | — | |
| SCHEMBL7732902 | 0.80 | CYP1A2 (1.00) | CYP1A2LMNAMAPK1HTTNOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494005-B1 | Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof | OREAL (FR) | 1997-02-05 | — | — | EP | claimed |
| US-5360804-A | STABILITY | L'OREAL (FR) | 1994-11-01 | — | — | US | claimed |
| EP-0494005-A1 | Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof | L'OREAL (FR) | 1992-07-08 | — | — | EP | claimed |
| US-20050049232-A1 | Composition | LINDAU PAR (SE) | 2005-03-03 | — | — | US | disclosed |
| EP-1463483-A1 | NEW COMPOSITION | Ponsus Pharma AB (SE) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003055454-A1 | NEW COMPOSITION | PONSUS PHARMA AB (SE) | 2003-07-10 | — | — | WO | disclosed |
| EP-0494005-B1 | Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof | OREAL (FR) | 1997-02-05 | — | — | EP | disclosed |
| US-5360804-A | STABILITY | L'OREAL (FR) | 1994-11-01 | — | — | US | disclosed |
| EP-0494005-A1 | Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof | L'OREAL (FR) | 1992-07-08 | — | — | EP | disclosed |
| EP-0187854-A4 | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR HAIR GROWTH PROMOTION. | BAZZANO GAIL S | 1987-01-22 | — | — | EP | disclosed |
| EP-0187854-A1 | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR HAIR GROWTH PROMOTION | BAZZANO, Gail S (US) | 1986-07-23 | — | — | EP | disclosed |
| WO-1986000616-A1 | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR HAIR GROWTH PROMOTION | BAZZANO GAIL SANSONE | 1986-01-30 | — | — | WO | disclosed |
| US-4393065-A | INCREASED PRODUCTIVITY OF BY-PRODUCTS BY INCLUSION OF PYRIMIDINE COMPOUNDS | THE UPJOHN COMPANY (US) | 1983-07-12 | — | — | US | disclosed |
| US-4316901-A | Animal feed and process | THE UPJOHN COMPANY (US) | 1982-02-23 | — | — | US | disclosed |
| US-4315930-A | A DIAMINO-TRIAZINE-3-OXIDE | THE UPJOHN COMPANY (US) | 1982-02-16 | — | — | US | disclosed |
| EP-0042669-A2 | Compounds and compositions for use in animal feeds | THE UPJOHN COMPANY (US) | 1981-12-30 | — | — | EP | disclosed |
| US-4308271-A | PYRIMIDINE OXIDE DERIVATIVES TO INCREASE PRODUCTION | THE UPJOHN COMPANY (US) | 1981-12-29 | — | — | US | disclosed |
| US-4307093-A | INCREASING PRODUCTION USING OXATRIAZINES | THE UPJOHN COMPANY (US) | 1981-12-22 | — | — | US | disclosed |
| US-4282228-A | Animal feed and process | THE UPJOHN COMPANY (US) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049232-A1 | Composition | CUTA, LIPG, LIPA | CYP1A2 582/4885LMNA 212/4885MAPK1 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.